tiprankstipranks
Trending News
More News >
Kura Oncology (KURA)
NASDAQ:KURA
US Market

Kura Oncology (KURA) Stock Forecast & Price Target

Compare
592 Followers
See the Price Targets and Ratings of:

KURA Analyst Ratings

Strong Buy
13Ratings
10 Buy
3 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Kura
Oncology
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

KURA Stock 12 Month Forecast

Average Price Target

$22.60
▲(275.42% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Kura Oncology in the last 3 months. The average price target is $22.60 with a high forecast of $40.00 and a low forecast of $10.00. The average price target represents a 275.42% change from the last price of $6.02.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","14":"$14","23":"$23","32":"$32","41":"$41"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$40.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$22.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$10.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,14,23,32,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.49,9.067692307692308,11.645384615384614,14.223076923076922,16.80076923076923,19.378461538461536,21.956153846153846,24.533846153846156,27.11153846153846,29.689230769230768,32.26692307692308,34.84461538461538,37.42230769230769,{"y":40,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.49,7.729230769230769,8.968461538461538,10.207692307692309,11.446923076923078,12.686153846153847,13.925384615384615,15.164615384615384,16.403846153846153,17.643076923076922,18.88230769230769,20.12153846153846,21.36076923076923,{"y":22.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.49,6.76,7.03,7.3,7.57,7.84,8.11,8.379999999999999,8.65,8.92,9.19,9.46,9.73,{"y":10,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":21.59,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.82,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.28,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.61,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.19,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.21,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.88,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.2,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.71,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.91,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.71,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.38,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.49,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$40.00Average Price Target$22.60Lowest Price Target$10.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on KURA
Jason ZemanskyBank of America Securities
Bank of America Securities
$29
Buy
381.73%
Upside
Reiterated
05/16/25
LifeSci Capital Analyst forecast on KURA
Charles ZhuLifeSci Capital
LifeSci Capital
$24
Buy
298.67%
Upside
Reiterated
05/14/25
BTIG
Hold
Reiterated
05/02/25
Scotiabank Analyst forecast on KURA
George FarmerScotiabank
Scotiabank
$10
Hold
66.11%
Upside
Reiterated
05/02/25
Wedbush
$36
Buy
498.01%
Upside
Reiterated
05/02/25
Barclays Analyst forecast on KURA
Peter LawsonBarclays
Barclays
$32$11
Buy
82.72%
Upside
Reiterated
05/02/25
H.C. Wainwright Analyst forecast on KURA
Joseph PantginisH.C. Wainwright
H.C. Wainwright
$40
Buy
564.45%
Upside
Reiterated
05/02/25
TD Cowen Analyst forecast on KURA
Phil NadeauTD Cowen
TD Cowen
Buy
Reiterated
05/01/25
Leerink Partners Analyst forecast on KURA
Jonathan ChangLeerink Partners
Leerink Partners
$23
Buy
282.06%
Upside
Reiterated
05/01/25
Citizens JMP Analyst forecast on KURA
Reni BenjaminCitizens JMP
Citizens JMP
$28
Buy
365.12%
Upside
Reiterated
04/29/25
UBS
$27$14
Buy
132.56%
Upside
Reiterated
03/06/25
Stifel Nicolaus Analyst forecast on KURA
Bradley CaninoStifel Nicolaus
Stifel Nicolaus
$11
Hold
82.72%
Upside
Reiterated
02/27/25
Mizuho Securities Analyst forecast on KURA
Salim SyedMizuho Securities
Mizuho Securities
Buy
Reiterated
02/26/25
Jefferies Analyst forecast on KURA
Roger SongJefferies
Jefferies
$28
Buy
365.12%
Upside
Assigned
01/22/25
Brookline Capital Markets Analyst forecast on KURA
Leah R. CannBrookline Capital Markets
Brookline Capital Markets
$35$40
Buy
564.45%
Upside
Reiterated
01/06/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on KURA
Jason ZemanskyBank of America Securities
Bank of America Securities
$29
Buy
381.73%
Upside
Reiterated
05/16/25
LifeSci Capital Analyst forecast on KURA
Charles ZhuLifeSci Capital
LifeSci Capital
$24
Buy
298.67%
Upside
Reiterated
05/14/25
BTIG
Hold
Reiterated
05/02/25
Scotiabank Analyst forecast on KURA
George FarmerScotiabank
Scotiabank
$10
Hold
66.11%
Upside
Reiterated
05/02/25
Wedbush
$36
Buy
498.01%
Upside
Reiterated
05/02/25
Barclays Analyst forecast on KURA
Peter LawsonBarclays
Barclays
$32$11
Buy
82.72%
Upside
Reiterated
05/02/25
H.C. Wainwright Analyst forecast on KURA
Joseph PantginisH.C. Wainwright
H.C. Wainwright
$40
Buy
564.45%
Upside
Reiterated
05/02/25
TD Cowen Analyst forecast on KURA
Phil NadeauTD Cowen
TD Cowen
Buy
Reiterated
05/01/25
Leerink Partners Analyst forecast on KURA
Jonathan ChangLeerink Partners
Leerink Partners
$23
Buy
282.06%
Upside
Reiterated
05/01/25
Citizens JMP Analyst forecast on KURA
Reni BenjaminCitizens JMP
Citizens JMP
$28
Buy
365.12%
Upside
Reiterated
04/29/25
UBS
$27$14
Buy
132.56%
Upside
Reiterated
03/06/25
Stifel Nicolaus Analyst forecast on KURA
Bradley CaninoStifel Nicolaus
Stifel Nicolaus
$11
Hold
82.72%
Upside
Reiterated
02/27/25
Mizuho Securities Analyst forecast on KURA
Salim SyedMizuho Securities
Mizuho Securities
Buy
Reiterated
02/26/25
Jefferies Analyst forecast on KURA
Roger SongJefferies
Jefferies
$28
Buy
365.12%
Upside
Assigned
01/22/25
Brookline Capital Markets Analyst forecast on KURA
Leah R. CannBrookline Capital Markets
Brookline Capital Markets
$35$40
Buy
564.45%
Upside
Reiterated
01/06/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kura Oncology

Which Analyst Should I Follow If I Want to Buy KURA and Sell After:
1 Month
xxx
Success Rate
12/18 ratings generated profit
67%
Average Return
-0.07%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of -0.07% per trade.
3 Months
xxx
Success Rate
25/43 ratings generated profit
58%
Average Return
+10.92%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.14% of your transactions generating a profit, with an average return of +10.92% per trade.
1 Year
Success Rate
7/17 ratings generated profit
41%
Average Return
+13.46%
reiterated a buy rating 18 days ago
Copying Robert Driscoll's trades and holding each position for 1 Year would result in 41.18% of your transactions generating a profit, with an average return of +13.46% per trade.
2 Years
xxx
Success Rate
22/43 ratings generated profit
51%
Average Return
+22.87%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 51.16% of your transactions generating a profit, with an average return of +22.87% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KURA Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
31
28
21
23
17
Buy
7
5
3
3
1
Hold
6
7
7
6
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
44
40
31
32
20
In the current month, KURA has received 18 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. KURA average Analyst price target in the past 3 months is 22.60.
Each month's total comprises the sum of three months' worth of ratings.

KURA Financial Forecast

KURA Earnings Forecast

Next quarter’s earnings estimate for KURA is -$0.18 with a range of -$0.86 to $2.28. The previous quarter’s EPS was -$0.66. KURA beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.73% of the time in the same period. In the last calendar year KURA has Outperformed its overall industry.
Next quarter’s earnings estimate for KURA is -$0.18 with a range of -$0.86 to $2.28. The previous quarter’s EPS was -$0.66. KURA beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.73% of the time in the same period. In the last calendar year KURA has Outperformed its overall industry.

KURA Sales Forecast

Next quarter’s sales forecast for KURA is $64.95M with a range of $0.00 to $375.00M. The previous quarter’s sales results were $14.11M. KURA beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 41.67% of the time in the same period. In the last calendar year KURA has Outperformed its overall industry.
Next quarter’s sales forecast for KURA is $64.95M with a range of $0.00 to $375.00M. The previous quarter’s sales results were $14.11M. KURA beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 41.67% of the time in the same period. In the last calendar year KURA has Outperformed its overall industry.

KURA Stock Forecast FAQ

What is KURA’s average 12-month price target, according to analysts?
Based on analyst ratings, Kura Oncology’s 12-month average price target is 22.60.
    What is KURA’s upside potential, based on the analysts’ average price target?
    Kura Oncology has 275.42% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is KURA a Buy, Sell or Hold?
          Kura Oncology has a consensus rating of Strong Buy which is based on 10 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Kura Oncology’s price target?
            The average price target for Kura Oncology is 22.60. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $40.00 ,the lowest forecast is $10.00. The average price target represents 275.42% Increase from the current price of $6.02.
              What do analysts say about Kura Oncology?
              Kura Oncology’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of KURA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis